Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Cardiac Injury Is Associated With Severe Outcome and Death in Patients With Coronavirus Disease 2019 (Covid-19) Infection: A Systematic Review and Meta-Analysis of Observational Studies
Abbass Soleimani
Abbass Soleimani

Associate Professor of Cardiology

Department Cardiology

School of Medicine

Sina Hospital

Tehran University of Medical Sciences

Related Documents
1. The Association Between Cardiac Injury and Outcomes in Hospitalized Patients With Covid-19, Internal and Emergency Medicine (2020)
All Documents
1. A Comparative Analysis of Echocardiographic Data for Heart Transplant Eligibility in Brain Death Cases, Egyptian Heart Journal (2025)
2. Prevalence of Coronary Artery Calcification in Non-Contrast Non Ecg-Gated Chest Ct Scan of Patients With Significant Stenosis in Conventional Angiography in Comparison to Patients Without Significant Stenosis: A Cross-Sectional Study, Health Science Reports (2025)
3. Risk Assessment for Mortality in Patients With St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Retrospective Cohort Study, Health Science Reports (2024)
4. Clinical and Angiographic Predictors of Suboptimal Coronary Flow After Primary Percutaneous Coronary Intervention in Patients With St-Elevation Myocardial Infarction, ARYA Atherosclerosis (2023)
5. Novel Treatment for Glance Necrosis Due to Priapism; Presentation and Review of Literature, Urologia Journal (2023)
6. Acute Electrocardiogram Pseudoinfarction Pattern and Re-Versible Left Ventricular Systolic Dysfunction in a Patient With Diabetic Ketoacidosis and Hyperkalemia: A Case Report, Frontiers in Emergency Medicine (2022)
7. Effects of Angiotensin Receptor Blockers (Arbs) on Clinical Outcomes of Patients With Hypertension and Covid-19: A 7-Month Follow-Up Cohort Study, Journal of Cardiovascular and Thoracic Research (2022)
8. The Outcomes of Marginal Donor Hearts Compared With Ideal Donors: A Single-Center Experience in Iran, Korean Journal of Transplantation (2022)
9. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
10. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
11. 24/7 Primary Percutaneous Coronary Intervention As a National Program, Critical Pathways in Cardiology (2021)
12. A Look at the Article the Relationship Between Philosophy and Medicine in the Works of Imam Fakhr Razi; a Distinctive Model From Galen and Ibn Sina, Iranian Journal of Medical Ethics and History of Medicine (2021)
13. Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive Covid-19 Patients: A Randomized Triple-Blind Clinical Trial, American Journal of Hypertension (2021)
14. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
15. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
16. The Primary Angioplasty Registry of Sina (Pars); a Brief Report of Design and Rationale, Frontiers in Emergency Medicine (2021)
17. Effects of Angiotensin Receptor Blockers (Arbs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected Covid-19, American Journal of Hypertension (2020)
18. The Association Between Cardiac Injury and Outcomes in Hospitalized Patients With Covid-19, Internal and Emergency Medicine (2020)
19. Myocardial Infarction in a Patient With Multiple Sclerosis After Receiving Natalizumab, Multiple Sclerosis and Related Disorders (2018)